Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model
Viruses · 13.01.2023 · 15 (1) · 230
DOI: 10.3390/v15010230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 13.01.2023. Verfasst von Alexandra Rak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Institute of Experimental Medicine, Saint Petersburg 197022, Russia. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
COVID-19 cases caused by new variants of highly mutable SARS-CoV-2 continue to be identified worldwide. Effective control of the spread of new variants can be achieved through targeting of conserved viral epitopes. In this regard, the SARS-CoV-2 nucleocapsid (N) protein, which is much more conserved than the evolutionarily influenced spike protein (S), is a suitable antigen. The recombinant N protein can be considered not only as a screening antigen but also as a basis for the development of next-generation COVID-19 vaccines, but little is known about induction of antibodies against the N protein via different SARS-CoV-2 variants. In addition, it is important to understand how antibodies produced against the antigen of one variant can react with the N proteins of other variants. Here, we used recombinant N proteins from five SARS-CoV-2 strains to investigate their immunogenicity and antigenicity in a mouse model and to obtain and characterize a panel of hybridoma-derived monoclonal anti-N antibodies. We also analyzed the variable epitopes of the N protein that are potentially involved in differential recognition of antiviral antibodies. These results will further deepen our knowledge of the cross-reactivity of the humoral immune response in COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology, Institute of Experimental Medicine, Saint Petersburg 197022, Russia.
- Department of Molecular Genetics, Institute of Experimental Medicine, Saint Petersburg 197022, Russia.
ORCID-Profile: Alexandra Rak, Nikolay Gorbunov, Valeria Kostevich, Alexey Sokolov, Irina Isakova-Sivak
Förderung
- Russian Science Foundation
Zitieren
APA
Rak, A., Gorbunov, N., Kostevich, V., Sokolov, A., Prokopenko, P., Rudenko, L., & Isakova-Sivak, I. (2023). Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model. Viruses, 15(1), 230. https://doi.org/10.3390/v15010230
Vancouver
Rak A, Gorbunov N, Kostevich V, Sokolov A, Prokopenko P, Rudenko L, et al. Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model. Viruses. 2023;15(1):230. doi:10.3390/v15010230
BibTeX
@article{Rak2023,
author = {Rak, Alexandra and Gorbunov, Nikolay and Kostevich, Valeria and Sokolov, Alexey and Prokopenko, Polina and Rudenko, Larisa and Isakova-Sivak, Irina},
title = {Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model},
journal = {Viruses},
year = {2023},
volume = {15},
number = {1},
pages = {230},
doi = {10.3390/v15010230}
}
EUVIMED